<DOC>
	<DOCNO>NCT00265252</DOCNO>
	<brief_summary>To determine cumulative incidence total hip replacement , time event treatment Fosamax placebo study peroid</brief_summary>
	<brief_title>Alendronate Prevention Collapse Femoral Head Non-Traumatic Osteonecrosis</brief_title>
	<detailed_description>To determine cumulative incidence total hip replacement collpase femoral head , time event treatment Fosamax placebo study peroid</detailed_description>
	<mesh_term>Osteonecrosis</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>osteonecrosis femoral head able provide sing informed consent prior bisphosphonate use pregnant lactate woman bilateral hip replacement</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>osteonecrosis</keyword>
	<keyword>total hip replacement</keyword>
</DOC>